Activities of cefepime and five other antibiotics against nosocomial PER-1-type and/or OXA-10-type beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter spp.
Vahaboglu
H
H
Saribaş
S
S
Akbal
H
H
Ozturk
R
R
Yucel
A
A
D000150:Acinetobacter / Q000145:classification / Q000187:drug effects* / Q000201:enzymology; D000151:Acinetobacter Infections / Q000382:microbiology; D000077723:Cefepime; D002511:Cephalosporins / Q000494:pharmacology* / Q000627:therapeutic use; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D008826:Microbial Sensitivity Tests; D009693:Nucleic Acid Hybridization; D011552:Pseudomonas Infections / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000145:classification / Q000187:drug effects* / Q000201:enzymology; D014421:Turkey; D001618:beta-Lactamases / Q000235:genetics / Q000378:metabolism
D002511:Cephalosporins; D000077723:Cefepime; D001618:beta-Lactamases